As illustrated in Fig. 2f–h, T2DM significantly reduced the levels of these proteins, but aFGF treatment appeared to attenuate the reduction of MPZ and MBP that observed in the nerves of T2DM + aFGF group. The gene discussed is MBP; the disease is type 2 diabetes mellitus.